Solitude Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Sell
3,910
-1,700
-30% -$97.6K 0.06% 39
2026
Q1
$325K Sell
5,610
-300
-5% -$17.5K 0.1% 34
2025
Q4
$319K Sell
5,910
-8,600
-59% -$414K 0.11% 33
2025
Q3
$654K Buy
14,510
+3,700
+34% +$173K 0.22% 29
2025
Q2
$500K Sell
10,810
-500
-4% -$24.5K 0.18% 28
2025
Q1
$690K Buy
11,310
+1,000
+10% +$58.3K 0.27% 24
2024
Q4
$583K Hold
10,310
0.26% 22
2024
Q3
$533K Buy
10,310
+1,509
+17% +$70.8K 0.23% 24
2024
Q2
$366K Buy
8,801
+2,801
+47% +$125K 0.17% 29
2024
Q1
$325K Buy
+6,000
New +$306K 0.15% 31

Other funds holding BMY

Solitude Financial Services's BMY Position: Q2 2026 in Review

Solitude Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 30% in Q2 2026, selling an estimated $97.6K and leaving 3,910 shares worth $225K. The position accounts for 0.06% of the portfolio, ranked #39.

Solitude Financial Services first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $690K in Q1 2025. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Solitude Financial Services held 3,910 shares of Bristol-Myers Squibb worth $225K as of Q2 2026.
  • Solitude Financial Services sold 1,700 Bristol-Myers Squibb shares in Q2 2026, an estimated $97.6K.
  • Bristol-Myers Squibb made up 0.06% of Solitude Financial Services's portfolio in Q2 2026, its #39 holding.
  • Solitude Financial Services first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
  • Solitude Financial Services's Bristol-Myers Squibb position peaked at $690K in Q1 2025.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Solitude Financial Services's 13F filing for Q2 2026, filed 24 Jul 2026.